New Key Statistics Module, Z-Score and F-Score
NAS:XERS Key Ratios
| Market Cap $ M | 281.68 |
| Enterprise Value $ M | 417.67 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 1.62 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 163.00 |
| EPS (TTM) $ | -0.44 |
| Beneish M-Score | -2.4 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 48.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -11.24 |
| EV-to-EBITDA | -17.47 |
| PEG | -- |
| Shares Outstanding M | 148.25 |
| Net Margin (%) | -37.98 |
| Operating Margin % | -26.85 |
| Pre-tax Margin (%) | -38.74 |
| Quick Ratio | 1.23 |
| Current Ratio | 1.64 |
| ROA % (ttm) | -18.92 |
| ROE % (ttm) | -362.12 |
| ROIC % (ttm) | -20.72 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.84 |
XERS Number of Guru Trades
XERS Volume of Guru Trades
Gurus Latest Trades with NAS:XERS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:XERS is held by these investors
Total 1
Xeris Biopharma Holdings Inc Insider Transactions
No Available Data
News about NAS:XERS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers